Welcome to our dedicated page for Enova International SEC filings (Ticker: ENVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Enova International's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Enova International's regulatory disclosures and financial reporting.
Enova International, Inc. (ENVA) reported that Executive Chairman David Fisher exercised and sold company stock in paired transactions. On August 25 and 26, 2026, he exercised non-qualified stock options for a total of 18,569 shares of common stock at an exercise price of $20.73 per share and acquired the same number of common shares. On those same dates, he sold all 18,569 shares in open-market transactions at weighted average prices of $244.01 (range $241.46–$251.20) and $239.16 (range $236.29–$244.93) per share, pursuant to a Rule 10b5-1 trading plan adopted on January 30, 2026. The exercised options, which were granted in tandem with a limited stock appreciation right, carry an exercise price of $20.73 and were scheduled to expire on February 11, 2027.
Enova International, Inc. (ENVA) is the issuer of common stock that David Fisher, identified as an officer, plans to sell under Rule 144. The notice covers a proposed sale of 28,500 shares of Enova common stock through Merrill Lynch, with an aggregate market value of $7,125,000 and 24,884,896 shares outstanding. The proposed sale date is August 25, 2026. The filing also lists several Enova common stock sales by David Fisher during the prior three months, each with specified share amounts and dollar values.
Enova International, Inc. (ENVA) disclosed that its wholly owned indirect subsidiary, NetCredit Combined Receivables B, LLC, issued $300,886,000 of asset-backed notes in the ENVA 2026-A securitization on August 21, 2026. The issuance consists of $240,709,000 Class A Notes, $44,341,000 Class B Notes, and $15,836,000 Class C Notes, backed by a pool of approximately $316.72 million of unsecured consumer installment loans pledged as collateral.
The Class A, B, and C Notes carry fixed coupons of 5.88%, 7.68%, and 10.64% per annum, respectively, and have a final maturity date of September 20, 2032. Net proceeds are being used to purchase the securitized receivables from Enova subsidiaries, fund a reserve account, and pay transaction fees and expenses. The notes are obligations of the issuer only and are not guaranteed by Enova.
The transaction is governed by an Indenture with Citibank, N.A. as Indenture Trustee and related agents, which imposes eligibility criteria on receivables and various covenants on the issuer. Breaches that are not cured may trigger acceleration of the notes, sale of receivables, and/or termination of the facility. The notes were privately offered to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S, without registration under the Securities Act.
Enova International, Inc., through its indirect subsidiary NC LOC 2024, amended its NetCredit LOC Receivables 2024 Facility by entering into a Third Amendment that increases the revolving commitment to $300,000,000 from $200,000,000, extends the revolving period to February 21, 2029, extends the maturity date to February 21, 2030, and reduces the borrowing rate to SOFR + 5.00% from SOFR + 5.50%.
Separately, an indirect subsidiary, NetCredit Combined Receivables B, LLC, priced an offering of $300,886,000 aggregate principal amount of asset-backed 2026-A Notes, consisting of $240,709,000 Class A Notes at 5.88%, $44,341,000 Class B Notes at 7.68%, and $15,836,000 Class C Notes at 10.64%. These notes will be backed by approximately $316.72 million of unsecured consumer installment loan receivables and will be obligations solely of the issuing subsidiary, not guaranteed by Enova.
Enova International reported an equity compensation grant to its General Counsel and Secretary, Sean Rahilly. He received 1,453 non-qualified stock options with a tandem limited stock appreciation right, at an exercise price of $257.79 per share, expiring on August 5, 2033. The options vest in substantially equal one-third increments on August 5 of 2027, 2028, and 2029, contingent on continued employment, and are exercisable for common stock subject to change-in-control and qualifying offer conditions described in the grant.
Enova International Chief Executive Officer Steven E. Cunningham received a grant of 7,359 non-qualified stock options paired with limited stock appreciation rights to acquire Enova common stock at an exercise price of $257.79 per share. These awards vest in three substantially equal annual installments on August 5, 2027, 2028 and 2029 and expire on August 5, 2033. The SAR component is exercisable only in connection with a defined Change in Control and a qualifying offer, with value based on the excess of an Offer Value Per Share over the option exercise price.
Enova International, Inc.'s Executive Chairman David Fisher received a grant of 6,190 non-qualified stock options on August 5, 2026, with an exercise price of $257.79 per share and expiration on August 5, 2033. The options vest in three equal annual installments from 2027 to 2029 and are paired with a limited stock appreciation right exercisable only upon a qualifying change in control and offer, as defined in the grant agreement.
Enova International reported that CFO Cornelis Scott received a grant of 1,500 non-qualified stock options with a tandem limited stock appreciation right, exercisable at $257.79 per share and expiring on August 5, 2033. The options vest in substantially equal one-third increments on August 5, 2027, August 5, 2028, and August 5, 2029, subject to continued employment. The related SAR becomes exercisable only for a 30-day period following a Change in Control and a qualifying offer, with value based on the excess of the Offer Value Per Share over the option exercise price.
Enova International granted Chief Strategy Officer Kirk Chartier a non-qualified stock option with a tandem limited stock appreciation right covering 2,095 shares of common stock at an exercise price of $257.79 per share. The option expires on August 5, 2033 and vests in substantially equal one-third increments on August 5, 2027, August 5, 2028 and August 5, 2029, contingent on continued employment. The SAR becomes exercisable only after a defined Change in Control and qualifying Offer, and pays the excess of the Offer Value Per Share over the exercise price on the shares exercised.
Veltre Maria reported acquisition or exercise transactions in this Form 4 filing.
Enova International, Inc. director Maria Veltre reported an equity compensation award of 772 Restricted Stock Units (RSUs) tied to common stock on August 5, 2026. The RSUs have no purchase price and 100% are scheduled to vest on August 5, 2027, contingent on her continued service on the board. Following this grant, she is reported as directly holding 772 units/shares.